$0.2667
-0.02-8.07%
At close: -
$0.2803
0.015.10%
After Hours: 5:07 PM EDT
Comments
Loading...
BioAtla Insider Trading Activity | NASDAQ:BCAB | Benzinga
Track the latest BioAtla insider trading activity. Stay informed on recent buys, sells, and market impact for BioAtla stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are BioAtla Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for BioAtla Inc
Shares Outstanding
58.401M
Insider Shares Owned
3.898M
Insider Percentage Owned
6.67%
Institutional Shares Held
4.531M
Institutional Percentage Held
7.76%
| Jan 19, 2024 | Sylvia McBrinn | DIRECTOR | 4.00K | $2.35 | $9.40K | BUY | 26.45% | 19.13K | Mar 28 | View |
| Dec 26, 2023 | Sylvia McBrinn | DIRECTOR | 4.00K | $2.33 | $9.32K | BUY | 35.96% | 15.13K | Dec 26 | View |
| Dec 20, 2023 | Jay M. Short | CHIEF EXECUTIVE OFFICER | 50.00K | $2.14 | $106.91K | BUY | 3.60% | 1.44M | Dec 20 | View |
| Dec 19, 2023 | Lawrence Steinman | DIRECTOR | 20.00K | $2.05 | $41.05K | BUY | 108.35% | 38.46K | Dec 19 | View |
| Dec 19, 2023 | Christian Vasquez | SEE REMARKS | 7.50K | $2.04 | $15.26K | BUY | 6.93% | 115.66K | Dec 19 | View |
| Sep 13, 2023 | Sylvia McBrinn | DIRECTOR | 2.00K | $2.54 | $5.08K | BUY | 21.92% | 11.13K | Sep 08 | View |
| Mar 30, 2023 | Jay M. Short | CHIEF EXECUTIVE OFFICER | 40.80K | $2.47 | $100.86K | BUY | 2.97% | 1.41M | Mar 29 | View |
| Mar 29, 2023 | Christian Vasquez | SEE REMARKS | 20.00K | $2.40 | $47.97K | BUY | 24.18% | 102.71K | Mar 28 | View |
| Dec 19, 2022 | Sylvia McBrinn | DIRECTOR | 3.70K | $8.33 | $30.81K | BUY | 68.20% | 9.13K | Dec 19 | View |
| Nov 23, 2022 | Sylvia McBrinn | DIRECTOR | 2.00K | $8.27 | $16.54K | BUY | 58.39% | 5.42K | Nov 22 | View |
| Sep 15, 2022 | Sylvia McBrinn | DIRECTOR | 3.00K | $8.63 | $25.90K | BUY | ∞ | 3.00K | Sep 12 - Sep 13 | View |
| Aug 15, 2022 | Jay M. Short | CHIEF EXECUTIVE OFFICER | 26.35K | $7.84 | $206.60K | BUY | 1.92% | 1.40M | Aug 12 | View |
| Jun 23, 2022 | Jay M. Short | CHIEF EXECUTIVE OFFICER | 69.39K | $2.86 | $198.34K | BUY | 5.31% | 1.38M | Jun 21 - Jun 22 | View |
| Jun 09, 2022 | Chris Vasquez | SEE REMARKS | 50.00K | $3.02 | $150.91K | BUY | 203.87% | 74.53K | Jun 07 - Jun 09 | View |
| Dec 07, 2021 | Richard A Waldron | CHIEF FINANCIAL OFFICER | -14.19K | $23.48 | -$333.15K | SELL | -9.55% | 134.47K | Nov 30 - Dec 02 | View |
| Dec 07, 2021 | Christian Vasquez | SEE REMARKS | -1.98K | $23.48 | -$46.46K | SELL | -7.27% | 25.26K | Nov 30 - Dec 02 | View |
| Dec 07, 2021 | Scott A. Smith | PRESIDENT | -4.09K | $22.27 | -$91.10K | SELL | -1.17% | 345.66K | Nov 30 - Dec 02 | View |
| Dec 07, 2021 | Eric Sievers | CHIEF MEDICAL OFFICER | -1.12K | $22.27 | -$25.03K | SELL | -1.21% | 91.51K | Nov 30 - Dec 02 | View |
| Dec 07, 2021 | Jay M. Short | CHIEF EXECUTIVE OFFICER | -47.62K | $23.48 | -$1.12M | SELL | -2.85% | 1.62M | Nov 30 - Dec 02 | View |
| Dec 06, 2021 | Richard A Waldron | CHIEF FINANCIAL OFFICER | -4.60K | $23.89 | -$109.87K | SELL | -3.00% | 148.66K | Nov 29 | View |
| Dec 06, 2021 | Christian Vasquez | SEE REMARKS | -642.00 | $23.89 | -$15.34K | SELL | -2.30% | 27.24K | Nov 29 | View |
| Dec 06, 2021 | Scott A. Smith | PRESIDENT | -399.00 | $23.89 | -$9.53K | SELL | -0.11% | 349.75K | Nov 29 | View |
| Dec 06, 2021 | Eric Sievers | CHIEF MEDICAL OFFICER | -110.00 | $23.89 | -$2.63K | SELL | -0.12% | 92.63K | Nov 29 | View |
| Dec 06, 2021 | Jay M. Short | CHIEF EXECUTIVE OFFICER | -15.44K | $23.89 | -$368.74K | SELL | -0.92% | 1.67M | Nov 29 | View |
| Nov 30, 2021 | Richard A Waldron | CHIEF FINANCIAL OFFICER | -13.33K | $25.26 | -$336.84K | SELL | -8.00% | 153.26K | Nov 22 - Nov 24 | View |
| Nov 30, 2021 | Christian Vasquez | SEE REMARKS | -2.54K | $25.26 | -$64.20K | SELL | -8.35% | 27.88K | Nov 22 - Nov 24 | View |
| Nov 30, 2021 | Scott A. Smith | PRESIDENT | -1.58K | $25.26 | -$39.92K | SELL | -0.45% | 350.14K | Nov 22 - Nov 24 | View |
| Nov 30, 2021 | Eric Sievers | CHIEF MEDICAL OFFICER | -434.00 | $25.26 | -$10.96K | SELL | -0.47% | 92.74K | Nov 22 - Nov 24 | View |
| Nov 30, 2021 | Jay M. Short | CHIEF EXECUTIVE OFFICER | -57.64K | $25.26 | -$1.46M | SELL | -3.31% | 1.69M | Nov 22 - Nov 24 | View |
| Nov 03, 2021 | Lawrence Steinman | DIRECTOR | -450.00 | $30.00 | -$13.50K | SELL | -2.38% | 18.46K | Nov 02 | View |
| Oct 07, 2021 | Scott Andrew Smith | PRESIDENT | -2.99K | $30.18 | -$90.35K | SELL | -0.84% | 351.73K | Oct 01 | View |
| Oct 07, 2021 | Eric Sievers | CHIEF MEDICAL OFFICER | -592.00 | $30.39 | -$17.99K | SELL | -0.63% | 93.17K | Oct 01 | View |
| Sep 17, 2021 | Lawrence Steinman | DIRECTOR | -450.00 | $36.82 | -$16.57K | SELL | -2.32% | 18.91K | Sep 15 | View |
| Aug 30, 2021 | Scott Andrew Smith | PRESIDENT | -33.24K | $40.16 | -$1.33M | SELL | -8.57% | 354.72K | Aug 26 | View |
| Aug 30, 2021 | Eric Sievers | CHIEF MEDICAL OFFICER | -6.88K | $39.59 | -$272.50K | SELL | -6.84% | 93.77K | Aug 26 | View |
| Aug 26, 2021 | Guy Levy Guy Levy | DIRECTOR | -546.71K | $39.65 | -$21.68M | SELL | -38.79% | 862.79K | Aug 24 | View |
| Aug 26, 2021 | Jay M. Short | CHIEF EXECUTIVE OFFICER | 3.21K | $29.80 | -$49.13K | SELL-OPTIONS | 0.29% | 1.10M | Aug 24 | View |
| Aug 18, 2021 | Lawrence Steinman | DIRECTOR | -450.00 | $40.60 | -$18.27K | SELL | -2.27% | 19.36K | Aug 16 | View |
| Jul 19, 2021 | Lawrence Steinman | DIRECTOR | -450.00 | $38.29 | -$17.23K | SELL | -2.22% | 19.81K | Jul 15 | View |
| Jun 22, 2021 | Jay M. Short | CHIEF EXECUTIVE OFFICER | -74.27K | $39.16 | -$2.91M | SELL | -3.22% | 2.23M | Jun 17 - Jun 21 | View |
| Jun 21, 2021 | Guy Levy Guy Levy | DIRECTOR | -400.00K | $39.16 | -$15.66M | SELL | -58.36% | 285.42K | Jun 17 | View |
| Jun 16, 2021 | Jay M. Short | CHIEF EXECUTIVE OFFICER | 2.42M | $40.06 | -$5.85M | ACQUISITION | ∞ | 864.60K | Jun 14 - Jun 16 | View |
| Dec 22, 2020 | Guy Levy Guy Levy | — | 3.18M | $18.00 | $25.00M | DERIVATIVE CONVERSION | ∞ | 348.20K | Dec 18 | View |
| Dec 22, 2020 | Cormorant Asset Management LPBihua ChenCormorant Global Healthcare Master Fund LPCormorant Private Healthcare Fund II LP | — | 2.29M | $18.00 | $14.40M | DERIVATIVE CONVERSION | ∞ | 2.29M | Dec 18 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.